Difference between revisions of "LINC01138"
| Line 10: | Line 10: | ||
===RefSeq(supplied by NCBI)=== | ===RefSeq(supplied by NCBI)=== | ||
NR_027468 | NR_027468 | ||
| − | + | LINC01138 | |
| − | |||
===Disease=== | ===Disease=== | ||
prostate cancer | prostate cancer | ||
Revision as of 14:24, 13 November 2017
Contents
Annotated Information
Approved Symbol
LINC01138C (long intergenic non-protein coding RNA 1138)
Previous Symbols
LINC00875
Synonyms
FLJ39739
Chromosome
1q21.2
RefSeq(supplied by NCBI)
NR_027468 LINC01138
Disease
prostate cancer
Expression
The expression level of LINC01138 is markedly increased in invasive extraprostatic tumors (pT3a, pT3b and T4 stages) as compared with intraprostatic localized tumors (pT2a , pT2b and pT2c stages).[1]
Function
The high level of LINC01138 is correlated with a short biochemical recurrence-free survival times.[1] LINC01138 promotes the proliferation and inhibited apoptosis of PCa.[1] LINC01138 functions as an oncogenes in prostate cancer.[1]
Labs working on this lncRNA
- State Key Laboratory of Genetic Engineering, Shanghai Engineering Research Center Of Industrial Microorganisms, School of Life Science, Fudan University, Shanghai 200433, PR China.
